Bayer starts Phase III trial on regorafenib in liver cancer
FRANKFURT (Reuters) - German drugmaker Bayer said on Wednesday it initiated a Phase III trial of its potential blockbuster drug regorafenib in patient...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/CWDMiKUVSow/story01.htm
No comments:
Post a Comment